Conservative treatment for breast cancer: long-term results (15 years). 1991

B Pierquin, and J Huart, and M Raynal, and Y Otmezguine, and E Calitchi, and J J Mazeron, and G Ganem, and J P Le Bourgeois, and G Marinello, and M Julien
Departement de Cancérologie, Hôpital Henri Mondor, Créteil, France.

From 1961 to 1974, 245 patients with unilateral "operable" breast cancer (25% T1, 56% T2, 19% T3) were treated with breast conservation and irradiation at the Gustave Roussy Institute (1961-1969) or at the Henri Mondor Hospital (1970-1974). The minimum follow-up is 15 years. Most patients with T greater than 3 cm underwent radiation therapy with the tumor in place, while the greater part of patients with T less than 3 cm received radiation therapy after tumorectomy. The breast and draining lymph node areas received widefield telecobalt irradiation to 45 Gy. The dose to the tumor site was boosted using iridium-192 implantation. Additional irradiation was given to the internal mammary and lower axillary nodes using an electron beam. The 15 years NED survival rate was 63%, 51% and 26% for T1, T2 and T3 tumors, respectively. The NED survival for T less than or equal to 1 cm was 86%. The local recurrence rate was 8, 12 and 19% for T1, T2 and T3 tumors, respectively. Of the patients with local recurrence, 85% underwent surgical salvage. Complications were rare. Cosmetic results were satisfactory in most patients including the T3 group. The proportion of breasts conserved among patients living NED at 15 years, was 97, 88 and 93% for T1, T2 and T3 tumors, respectively. In 1980, after almost 20 years experience using breast conserving techniques, we modified our treatment policies in close collaboration with our surgical team, hel cbye extending the indications for tumorectomy and associating routine surgical exploration of the lower axilla.

UI MeSH Term Description Entries
D008408 Mastectomy Surgical procedure to remove one or both breasts. Mammectomy,Mammectomies,Mastectomies
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011867 Radioisotope Teletherapy A type of high-energy radiotherapy using a beam of gamma-radiation produced by a radioisotope source encapsulated within a teletherapy unit. Teleradioisotope Therapy,Teletherapy, Radioisotope,Therapy, Teleradioisotope
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003037 Cobalt Radioisotopes Unstable isotopes of cobalt that decay or disintegrate emitting radiation. Co atoms with atomic weights of 54-64, except 59, are radioactive cobalt isotopes. Radioisotopes, Cobalt
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015412 Mastectomy, Segmental Removal of only enough breast tissue to ensure that the margins of the resected surgical specimen are free of tumor. Breast-Conserving Surgery,Lumpectomy,Partial Mastectomy,Breast Conservation Therapy,Breast Quadrantectomy,Breast-Sparing Surgery,Limited Resection Mastectomy,Local Excision Mastectomy,Segmentectomy,Surgery, Breast-Conserving,Breast Conservation Therapies,Breast Conserving Surgery,Breast Quadrantectomies,Breast Sparing Surgery,Breast-Conserving Surgeries,Breast-Sparing Surgeries,Conservation Therapies, Breast,Conservation Therapy, Breast,Limited Resection Mastectomies,Local Excision Mastectomies,Lumpectomies,Mastectomies, Limited Resection,Mastectomies, Local Excision,Mastectomies, Partial,Mastectomies, Segmental,Mastectomy, Limited Resection,Mastectomy, Local Excision,Mastectomy, Partial,Partial Mastectomies,Quadrantectomies, Breast,Quadrantectomy, Breast,Segmental Mastectomies,Segmental Mastectomy,Segmentectomies,Surgeries, Breast-Conserving,Surgeries, Breast-Sparing,Surgery, Breast Conserving,Surgery, Breast-Sparing

Related Publications

B Pierquin, and J Huart, and M Raynal, and Y Otmezguine, and E Calitchi, and J J Mazeron, and G Ganem, and J P Le Bourgeois, and G Marinello, and M Julien
January 1975, Annals of surgery,
B Pierquin, and J Huart, and M Raynal, and Y Otmezguine, and E Calitchi, and J J Mazeron, and G Ganem, and J P Le Bourgeois, and G Marinello, and M Julien
February 1986, Presse medicale (Paris, France : 1983),
B Pierquin, and J Huart, and M Raynal, and Y Otmezguine, and E Calitchi, and J J Mazeron, and G Ganem, and J P Le Bourgeois, and G Marinello, and M Julien
August 2001, Magyar sebeszet,
B Pierquin, and J Huart, and M Raynal, and Y Otmezguine, and E Calitchi, and J J Mazeron, and G Ganem, and J P Le Bourgeois, and G Marinello, and M Julien
October 1990, Pathologie-biologie,
B Pierquin, and J Huart, and M Raynal, and Y Otmezguine, and E Calitchi, and J J Mazeron, and G Ganem, and J P Le Bourgeois, and G Marinello, and M Julien
July 1969, The Journal of urology,
B Pierquin, and J Huart, and M Raynal, and Y Otmezguine, and E Calitchi, and J J Mazeron, and G Ganem, and J P Le Bourgeois, and G Marinello, and M Julien
April 1970, Bulletin des societes d'ophtalmologie de France,
B Pierquin, and J Huart, and M Raynal, and Y Otmezguine, and E Calitchi, and J J Mazeron, and G Ganem, and J P Le Bourgeois, and G Marinello, and M Julien
May 2023, Archives of plastic surgery,
B Pierquin, and J Huart, and M Raynal, and Y Otmezguine, and E Calitchi, and J J Mazeron, and G Ganem, and J P Le Bourgeois, and G Marinello, and M Julien
August 2007, Breast (Edinburgh, Scotland),
B Pierquin, and J Huart, and M Raynal, and Y Otmezguine, and E Calitchi, and J J Mazeron, and G Ganem, and J P Le Bourgeois, and G Marinello, and M Julien
February 1989, Archives of surgery (Chicago, Ill. : 1960),
B Pierquin, and J Huart, and M Raynal, and Y Otmezguine, and E Calitchi, and J J Mazeron, and G Ganem, and J P Le Bourgeois, and G Marinello, and M Julien
February 1947, Schweizerische medizinische Wochenschrift,
Copied contents to your clipboard!